Molecular resistance mechanisms of ALK inhibitors and implications for therapeutic management of ALK-rearranged lung cancer patients.
Name:
tcr-06-S2-S239.pdf
Size:
420.5Kb
Format:
PDF
Description:
Full text, Open Access article
Affiliation
Department of Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, ShanghaiIssue Date
2017-03
Metadata
Show full item recordCitation
Molecular resistance mechanisms of ALK inhibitors and implications for therapeutic management of ALK-rearranged lung cancer patients. 2017, 6 (S2):S239-245 Translational Cancer ResearchJournal
Translational Cancer ResearchDOI
10.21037/tcr.2017.03.22Additional Links
http://tcr.amegroups.com/article/view/12809/10721Type
ArticleLanguage
enISSN
2218676X22196803
ae974a485f413a2113503eed53cd6c53
10.21037/tcr.2017.03.22